These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23646245)

  • 21. Pralidoxime inhibits paraoxon-induced depression of rocuronium-neuromuscular block in a time-dependent fashion.
    Narimatsu E; Niiya T; Takahashi K; Yamauchi M; Yamakage M
    Am J Emerg Med; 2012 Jul; 30(6):901-7. PubMed ID: 21871755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Zidovudine and its interaction with rocuronium on neuromuscular transmission.
    Barvaliya MJ; Patel TK; Patel JC; Tripathi CB
    Indian J Pharm Sci; 2013 Mar; 75(2):191-6. PubMed ID: 24019568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone concentration affecting rocuronium-induced neuromuscular blockade and sugammadex reversal in a rat phrenic nerve-hemidiaphragm model: An ex vivo study.
    In J; Bae H; Choi H; Kim YB; Lee S; Yang HS
    Eur J Anaesthesiol; 2018 Nov; 35(11):856-862. PubMed ID: 30045055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hyperthermia on the effective concentration of rocuronium and sugammadex-mediated reversal in isolated phrenic nerve hemidiaphragm preparations of rats.
    Kim JS; Kim YM; Kim HJ; Choi JM; Kim YB; Song JS; Yang HS
    BMC Anesthesiol; 2020 Aug; 20(1):194. PubMed ID: 32767970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversibility of Rocuronium-Induced Deep Neuromuscular Block with Sugammadex in Infants and Children-A Randomized Study.
    Matsui M; Konishi J; Suzuki T; Sekijima C; Miyazawa N; Yamamoto S
    Biol Pharm Bull; 2019 Oct; 42(10):1637-1640. PubMed ID: 31406051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation.
    Audibert G; Donati F
    Anesth Analg; 1996 Apr; 82(4):848-53. PubMed ID: 8615509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming with rocuronium accelerates the onset of neuromuscular blockade.
    Griffith KE; Joshi GP; Whitman PF; Garg SA
    J Clin Anesth; 1997 May; 9(3):204-7. PubMed ID: 9172027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of stimulus frequency on blockade induced by pancuronium and rocuronium: study on rats phrenic nerve-diaphragm preparation.
    Braga Ade F; Munoz DC; Braga FS; Araujo DR; Potério GM; Mantovani M
    Acta Cir Bras; 2007; 22(6):446-50. PubMed ID: 18235932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats.
    Staals LM; de Boer HD; van Egmond J; Hope F; van de Pol F; Bom AH; Driessen JJ; Booij LH
    J Anesth; 2011 Apr; 25(2):241-6. PubMed ID: 21225291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of magnesium sulfate concentration on the effective concentration of rocuronium, and sugammadex-mediated reversal, in isolated left phrenic nerve hemi-diaphragm preparations from the rat.
    Cho CK; Sung TY; Choi SJ; Choi HR; Kim YB; Lee JU; Yang HS
    Korean J Anesthesiol; 2018 Oct; 71(5):401-406. PubMed ID: 29843202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin.
    Spacek A; Nickl S; Neiger FX; Nigrovic V; Ullrich OW; Weindmayr-Goettel M; Schwall B; Taeger K; Kress HG
    Anesthesiology; 1999 Jun; 90(6):1551-5. PubMed ID: 10360851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient.
    Iwasaki H; Takahoko K; Otomo S; Sasakawa T; Kunisawa T; Iwasaki H
    J Anesth; 2014 Apr; 28(2):288-90. PubMed ID: 23963464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of age on maintenance of intense neuromuscular block with rocuronium.
    Furuya T; Suzuki T; Kashiwai A; Konishi J; Aono M; Hirose N; Kato J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):236-9. PubMed ID: 22236347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of stimulation frequency on rocuronium and pancuronium-induced neuromuscular block onset. Acceleromyography evaluation.
    Munhóz Dda C; Braga Ade F; Potério GM
    Rev Bras Anestesiol; 2004 Feb; 54(1):3-12. PubMed ID: 19471705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone produces dose-dependent inhibition of sugammadex reversal in in vitro innervated primary human muscle cells.
    Rezonja K; Sostaric M; Vidmar G; Mars T
    Anesth Analg; 2014 Apr; 118(4):755-63. PubMed ID: 24651229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.